How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Automatic Parallel Peptide Synthesiser Market
- By Product Type: Automated Solid Phase Peptide Synthesizers, Automated Liquid Phase Peptide Synthesizers, Automated Parallel Peptide Synthesizers with Microwave Assistance, Automated Parallel Peptide Synthesizers with UV Detection
- By Application: Drug Discovery and Development, Proteomics Research, Biotechnology and Life Sciences Research, Academic and Government Research, Cosmetic Peptide Synthesis
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Cosmetic Industry, Diagnostic Laboratories
- By Synthesis Scale: Microscale Synthesis, Milligram Scale Synthesis, Gram Scale Synthesis
- By Technology: Fmoc Chemistry Based Synthesizers, Boc Chemistry Based Synthesizers, Hybrid Chemistry Synthesizers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Automated Solid Phase Peptide Synthesizers leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 10 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 10 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Automatic Parallel Peptide Synthesiser Market report
A complete, evidence-based study - 12 chapters and 118 sections covering market size, segmentation across 5 axes, regional analysis and 10 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Application 5
End User 5
Synthesis Scale 3
Technology 3
Companies profiled
CEM Corporation
Biotage AB
Aapptec
Gyros Protein Technologies
CSBio
Intavis Bioanalytical Instruments AG
Peptide Synthetics Ltd
Shimadzu Corporation
Protein Technologies Inc.
Inc.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
10 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →CEM Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Biotage AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Aapptec
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Gyros Protein Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →CSBio
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →Intavis Bioanalytical Instruments AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Peptide Synthetics Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Shimadzu Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Protein Technologies Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.202 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,053M by 2033 · 3.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Automated Solid Phase Peptide Synthesizers50.4
- Automated Liquid Phase Peptide Synthesizers19.5
- Automated Parallel Peptide Synthesizers with Microwave Assistance15.1
- Automated Parallel Peptide Synthesizers with UV Detection15.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$987.2M → $1,283M · 3.3%
Europe$688.1M → $835.6M · 2.5%
Asia Pacific$628.2M → $882.6M · 4.3%
Latin America$388.9M → $503.6M · 3.3%
Middle East and Africa$299.2M → $389.6M · 3.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.822026
3.832027
3.852028
3.852029
3.862030
3.892031
3.892032
3.902033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- CEM Corporation10.6
- Biotage AB26.4
- Aapptec10.4
- Gyros Protein Technologies6.4
- CSBio9.1
- Intavis Bioanalytical Instruments AG9.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type26.3%
Application22.9%
End User18.1%
Synthesis Scale11.9%
Technology20.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.9
- Europe21.5
- Asia Pacific22.7
- Latin America12.9
- Middle East and Africa10.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| CEM Corporation | 75 | 84 | 90 | 83 | 92 | 78 | 84 |
| Biotage AB | 91 | 70 | 77 | 78 | 80 | 80 | 79 |
| Aapptec | 69 | 76 | 85 | 85 | 66 | 81 | 77 |
| Gyros Protein Technologies | 81 | 62 | 81 | 81 | 66 | 61 | 72 |
| CSBio | 72 | 57 | 58 | 68 | 69 | 65 | 65 |
| Intavis Bioanalytical Instruments AG | 51 | 60 | 70 | 64 | 69 | 52 | 61 |
| Peptide Synthetics Ltd | 55 | 55 | 65 | 58 | 63 | 57 | 59 |
| Shimadzu Corporation | 59 | 59 | 44 | 53 | 50 | 53 | 53 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- CEM Corporation
- Biotage AB
- Aapptec
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| CEM Corporation | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Biotage AB | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Aapptec | − | ✓ | ✓ | ◐ | − | ✓ |
| Gyros Protein Technologies | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| CSBio | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Intavis Bioanalytical Instruments AG | ◐ | − | ◐ | ◐ | ◐ | − |
| Peptide Synthetics Ltd | − | − | ◐ | − | − | − |
| Shimadzu Corporation | − | − | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1CEM Corporation84
2Biotage AB79
3Aapptec77
4Gyros Protein Technologies72
5CSBio65
6Intavis Bioanalytical Instruments AG61
7Peptide Synthetics Ltd59
8Shimadzu Corporation53
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
CEM CorporationBiotage AB
Challenger2
Strong scale, closing on the leaders.
AapptecGyros Protein Technologies
Contender3
Focused players with pockets of strength.
CSBioIntavis Bioanalytical Instruments AGPeptide Synthetics Ltd
Niche1
Specialists in a single segment or region.
Shimadzu Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Automatic Parallel Peptide Synthesiser Market — a $234M beachhead inside a $3.60B market.
Beachhead (SOM)$234Mobtainable near-term
Serviceable (SAM)$1.44Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Automated Solid Phase Peptide Synthesizers
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Automated Liquid Phase Peptide Synthesizers
Strong fit — clear ROI and a fast path to value.
End user67 fit
Automated Parallel Peptide Synthesizers with Microwave Assistance
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Automatic Parallel Peptide Synthesiser Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified23%
Evaluation11%
Closed-won7%
$12.6KCAC
$44KLTV
3.5:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Automatic Parallel Peptide Synthesiser Market is a high-growth opportunity — $5.44B by 2033, compounding at 11.5%.
TAM · 2025$2.28Btoday
TAM · 2033$5.44Bforecast
CAGR11.5%2027–2033
Cumulative$33.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.44BTotal addressable market
SAM$1.90BServiceable available market
SOM$387MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
10+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.44BLarge & growingTAM by 2033 at 11.5% CAGR
$1.90BServiceable nowreachable with today’s model
$387MBeachhead winobtainable near-term share
10+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.24BBear7.4% CAGR
$5.44BBase11.5% CAGR
$6.96BBull15.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Automatic Parallel Peptide Synthesiser Market — a $6.40B market by 2033. Plan: grow share from 8.3% to 13.0%.
Market size · 2033$6.40Btotal addressable
Market CAGR11.5%2027–2033
Target share13.0%from 8.3% today
Revenue ambition$832Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.3% | 13.0% | Ahead |
| Revenue | $577M | $832M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 32.4% | 41.6% | Ahead |
| Customer retention | 89.5% | 95.6% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $125M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Automatic Parallel Peptide Synthesiser Market conversation — a $5.17B market you can size, segment and defend in minutes.
Market size · 2033$5.17Btotal opportunity
Growth6.6%CAGR to 2033
Addressable buyers1,121+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 3 mopayback period
$82K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
10+players profiled in this market
Coverage includes
CEM CorporationBiotage ABAapptecGyros Protein TechnologiesCSBioIntavis Bioanalytical Instruments AGPeptide Synthetics LtdShimadzu Corporation+2 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Automatic Parallel Peptide Synthesiser Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Automatic Parallel Peptide Synthesiser Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Automatic Parallel Seam Welder Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportAutomatic Parking Barrier Gates Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportAutomatic Parking System Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportAutomatic Parts Washer Cabinets Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportAutomatic Passenger Counting and Information Systems Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportAutomatic Passport Production Systems Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportAutomatic Patch Clamp System Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportAutomatic Paver Block Making Machine Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportAutomatic PCB Laser Marking Machine Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportAutomatic Pedestrian Doors Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportAutomatic Personnel Contamination Monitors Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportAutomatic PET Blow Molding Machines Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.